Literature DB >> 32001415

Identifying Disparities in Care in Treating Glioblastoma: A Retrospective Cohort Study of Patients Treated at a Safety-net Versus Private Hospital Setting.

Theodore Wang1, Anthony Pham2, Stella Yoo3, Frank J Attenello4, Richard Jennelle3, Naveed Wagle5, Eric L Chang3, Gabriel Zada1.   

Abstract

BACKGROUND: Patients of lower socioeconomic status (SES) may experience barriers to their oncologic care, but current data conflict over whether SES affects the prognosis of patients with glioblastoma (GB).
OBJECTIVE: We sought to determine whether SES disparities impaired delivery of neuro-oncologic care and affected the prognosis of GB patients.
METHODS: The records of GB patients treated from 2010 to 2014 at a safety-net hospital (SNH) or private hospital (PH), both served by 1 academic medical institution, were retrospectively reviewed and compared. Overall survival (OS) and progression-free survival (PFS) were estimated using the Kaplan-Meier method.
RESULTS: A total of 55 SNH and 39 PH GB patients were analyzed with median 11-month follow-up. SNH patients were predominantly Hispanic, low income, enrolled in Medicaid, were less likely to receive radiation (89% vs. 100%), took longer to start radiation (41 vs. 29 days), and were less likely to complete radiation treatment (80% vs. 95%). Concurrent and adjuvant temozolomide use were also lower (85% vs. 94% and 60% vs. 71%, respectively). OS and PFS were not significantly different (15 vs. 16 months and 8 vs. 11 months, respectively). On multivariate analysis, adjuvant chemotherapy and RT completion predicted for better OS, whereas hospital type, income, and insurance did not.
CONCLUSION: Although GB patients at our SNH received less adjuvant treatment compared with PH, outcomes were similar. Access to multidisciplinary care staffed by academic physicians may play an important role in overcoming socioeconomic barriers to treatment availability and quality at SNHs.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Disparities; Glioblastoma; Outcomes

Mesh:

Substances:

Year:  2020        PMID: 32001415      PMCID: PMC8908807          DOI: 10.1016/j.wneu.2020.01.133

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  24 in total

1.  Effects of socioeconomic and geographic variations on survival for adult glioma in England and Wales.

Authors:  Jen-Ho Tseng; Edwin Merchant; Ming-Yuan Tseng
Journal:  Surg Neurol       Date:  2006-09

2.  Developing an Algorithm for Optimizing Care of Elderly Patients With Glioblastoma.

Authors:  Patrick M Flanigan; Arman Jahangiri; Ruby Kuang; Albert Truong; Sarah Choi; Alvin Chou; Annette M Molinaro; Michael W McDermott; Mitchel S Berger; Manish K Aghi
Journal:  Neurosurgery       Date:  2018-01-01       Impact factor: 4.654

3.  Validation and simplification of the Radiation Therapy Oncology Group recursive partitioning analysis classification for glioblastoma.

Authors:  Jing Li; Meihua Wang; Minhee Won; Edward G Shaw; Christopher Coughlin; Walter J Curran; Minesh P Mehta
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-10-01       Impact factor: 7.038

4.  Incidence, survival, pathology, and genetics of adult Latino Americans with glioblastoma.

Authors:  Maryam Shabihkhani; Donatello Telesca; Masoud Movassaghi; Yalda B Naeini; Kourosh M Naeini; Seyed Amin Hojat; Diviya Gupta; Gregory M Lucey; Michael Ontiveros; Michael W Wang; Lauren S Hanna; Desiree E Sanchez; Sergey Mareninov; Negar Khanlou; Harry V Vinters; Marvin Bergsneider; Phioanh Leia Nghiemphu; Albert Lai; Linda M Liau; Timothy F Cloughesy; William H Yong
Journal:  J Neurooncol       Date:  2017-02-04       Impact factor: 4.130

5.  The effect of socioeconomic status on gross total resection, radiation therapy and overall survival in patients with gliomas.

Authors:  Sayantan Deb; Arjun Vivek Pendharkar; Matthew K Schoen; Sean Altekruse; John Ratliff; Atman Desai
Journal:  J Neurooncol       Date:  2017-03-03       Impact factor: 4.130

6.  Treatment disparities following the diagnosis of an astrocytoma.

Authors:  Paula R Sherwood; Bassam A Dahman; Heidi S Donovan; Arlan Mintz; Charles W Given; Cathy J Bradley
Journal:  J Neurooncol       Date:  2010-05-22       Impact factor: 4.130

7.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.

Authors:  Roger Stupp; Warren P Mason; Martin J van den Bent; Michael Weller; Barbara Fisher; Martin J B Taphoorn; Karl Belanger; Alba A Brandes; Christine Marosi; Ulrich Bogdahn; Jürgen Curschmann; Robert C Janzer; Samuel K Ludwin; Thierry Gorlia; Anouk Allgeier; Denis Lacombe; J Gregory Cairncross; Elizabeth Eisenhauer; René O Mirimanoff
Journal:  N Engl J Med       Date:  2005-03-10       Impact factor: 91.245

8.  Comparison between poor and long-term survivors with glioblastoma: review of an Australian dataset.

Authors:  Kathryn Maree Field; Mark Andrew Rosenthal; Merve Yilmaz; Mark Tacey; Kate Drummond
Journal:  Asia Pac J Clin Oncol       Date:  2013-05-22       Impact factor: 2.601

9.  Revisiting the Relationship Between Ethnicity and Outcome in Glioblastoma Patients.

Authors:  Ashish H Shah; Eric Barbarite; Christopher Scoma; Manish Kuchakulla; Sahil Parikh; Amade Bregy; Ricardo J Komotar
Journal:  Cureus       Date:  2017-01-04

10.  Socioeconomic status does not affect prognosis in patients with glioblastoma multiforme.

Authors:  Rebecca A Kasl; Philip R Brinson; Lola B Chambless
Journal:  Surg Neurol Int       Date:  2016-05-06
View more
  3 in total

1.  Racial/ethnic disparities in treatment pattern and time to treatment for adults with glioblastoma in the US.

Authors:  Quinn T Ostrom; Halle L Krebs; Nirav Patil; Gino Cioffi; Jill S Barnholtz-Sloan
Journal:  J Neurooncol       Date:  2021-03-23       Impact factor: 4.130

2.  Surgical Management of a Massive Frontal Bone Hemangioma: Case Report.

Authors:  Cylaina E Bird; Jeffrey I Traylor; Zachary D Johnson; Jun Kim; Jack Raisanen; Babu G Welch; Kalil G Abdullah
Journal:  J Neurol Surg Rep       Date:  2022-07-10

3.  Overcoming Barriers to Radiation Oncology Access in Low-Resource Settings in the United States.

Authors:  Malcolm D Mattes; Gita Suneja; Bruce G Haffty; Cristiane Takita; Matthew S Katz; Nitin Ohri; Curtiland Deville; Malika L Siker; Henry S Park
Journal:  Adv Radiat Oncol       Date:  2021-09-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.